New Corona Vaccine China “Production for about 600 million times by the end of the year” Forecast September 26, 22:14
Regarding the new coronavirus vaccine being developed by Chinese pharmaceutical companies, the Chinese government expects that it will be able to produce about 600 million doses by the end of the year, saying that four types are in the final stage of clinical trials. Shown.
At a press conference on the 25th, China's Ministry of Science and Technology Director Wu En-Ai said that 11 types of vaccines are undergoing clinical trials, and 4 of them are in the final stages. It's going well. "
The final stage of clinical trials is also being conducted overseas, and the two vaccines being developed by the state-owned company "China Biotechnology" have been administered to more than 35,000 people in the Middle East, and there are no noticeable problems. is.
In addition, the vaccine of the pharmaceutical company "Sinobac" is being developed in South America and Southeast Asia, and the vaccine being jointly developed by "Cansino Biologics" and the PLA Institute is in Asia and Europe, respectively, and the final stage clinical trials are being conducted. That is.
The expert who attended said that the phenomenon called ADE = "antibody-dependent enhancement", in which the virus infection and proliferation are strengthened by the vaccine, has not been confirmed so far.
In addition, National Health Commission Chief Chung Zhongwei said that by the end of this year, 610 million vaccines could be produced, and next year more than one billion vaccines could be produced.
It seems that the aim of strengthening international influence is behind the appeal that the development of vaccines is proceeding smoothly.